AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?

What happened

Summary assembled by rule from the sources below

Timeline

1. 19:38
   First appeared on Yahoo FinanceYahoo Finance

Sources